{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T03:55:24Z","timestamp":1792295724010,"version":"4.4.0"},"reference-count":52,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"vor","delay-in-days":144,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000890","name":"National Multiple Sclerosis Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Australian National Health and Medical Research Council"},{"DOI":"10.13039\/501100000924","name":"Multiple Sclerosis Research Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000924","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Australian Medical Research Future Fund"},{"DOI":"10.13039\/501100000925","name":"NHMRC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Multiple Sclerosis Research Australia Postgraduate Scholarship"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>In Ausimmune, an Australian multicenter incident case\u2013control study, Epstein\u2013Barr virus (EBV)-related measures, including anti-EBNA antibodies and infectious mononucleosis, show multiple sclerosis (MS) associations mediated by DNA methylation (DNAm). Human herpesvirus-6 (HHV-6) DNA has also been linked to increased MS onset risk, though its mechanisms remain unknown. Therefore, we examined an expanded set of human herpesvirus indices including HHV-6 indices. We first tested associations with MS-associated DNAm modules, then assessed whether HHV-6 DNA contributes to MS onset through DNAm pathways. Serological (serum) and viral load (whole blood) measures of EBV (DNA, viral capsid antigen, early antigen diffuse and restricted), HHV-6 (DNA, IgM, IgG), cytomegalovirus (CMV) (IgG), and varicella zoster virus (DNA, IgG) were collected. DNAm was measured from whole blood (Illumina Infinium Human Methylation EPIC v1). DNAm-module (A1\u2013A5) scores were derived using an epigenome-wide association study for MS onset risk and dimension-reduction methods. A total of 206 cases and 348 matched controls were analyzed. Multivariable linear regression demonstrated associations between HHV-6 DNA positivity and the A2-module, and between higher CMV IgG and the A4 module. Counterfactual mediation analysis indicated that 45% of the positive association of HHV-6 DNA positivity with MS onset risk was mediated through the A2 module (Pindirect\u00a0= .008). The A2 module showed enrichment for lymphatic and immune pathways. These results provide evidence for a distinct DNAm module as a plausible mechanism underlying the associations of HHV-6 with MS onset. Importantly, these epigenetic pathways appear to mediate associations with human herpesviruses beyond EBV. These findings provide further insights into how environmental factors relate to MS onset through epigenetic programming.<\/jats:p>","DOI":"10.1093\/eep\/dvag016","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T11:44:09Z","timestamp":1779363849000},"source":"Crossref","is-referenced-by-count":1,"title":["DNA methylation mediates the multiple sclerosis onset risk associated with HHV-6 DNA positivity"],"prefix":"10.1093","volume":"12","author":[{"given":"Alex","family":"Eisner","sequence":"first","affiliation":[{"name":"The Florey Institute of Neuroscience and Mental Health, The University of Melbourne , Parkville, 3010 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Simpson-Yap","sequence":"additional","affiliation":[{"name":"The Florey Institute of Neuroscience and Mental Health, The University of Melbourne , Parkville, 3010 ,","place":["Australia"]},{"name":"Neuroepidemiology Unit, Melbourne School of Population & Global Health, The University of Melbourne , Carlton, 3053 ,","place":["Australia"]},{"name":"MS Research Flagship, Menzies Institute for Medical Research, University of Tasmania , Hobart, 7000 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J","family":"Park","sequence":"additional","affiliation":[{"name":"Melbourne Bioinformatics, The University of Melbourne , Parkville, 3051 ,","place":["Australia"]},{"name":"The University of Melbourne Department of Biochemistry and Pharmacology, , Parkville, 3051 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Morwitch","sequence":"additional","affiliation":[{"name":"The Florey Institute of Neuroscience and Mental Health, The University of Melbourne , Parkville, 3010 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Tanner","sequence":"additional","affiliation":[{"name":"The Florey Institute of Neuroscience and Mental Health, The University of Melbourne , Parkville, 3010 ,","place":["Australia"]},{"name":"Melbourne Bioinformatics, The University of Melbourne , Parkville, 3051 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3785-4742","authenticated-orcid":false,"given":"Vicki E","family":"Maltby","sequence":"additional","affiliation":[{"name":"School of Biomedical Sciences and Pharmacy, University of Newcastle , Callaghan, 2308 ,","place":["Australia"]},{"name":"Immune Health Program, Hunter Medical Research Institute , New Lambton Heights, 2305 ,","place":["Australia"]},{"name":"John Hunter Hospital Department of Neurology, , New Lambton Heights, 2305 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9009-7472","authenticated-orcid":false,"given":"Ingrid","family":"van\u00a0der\u00a0Mei","sequence":"additional","affiliation":[{"name":"MS Research Flagship, Menzies Institute for Medical Research, University of Tasmania , Hobart, 7000 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeannette","family":"Lechner-Scott","sequence":"additional","affiliation":[{"name":"School of Biomedical Sciences and Pharmacy, University of Newcastle , Callaghan, 2308 ,","place":["Australia"]},{"name":"Immune Health Program, Hunter Medical Research Institute , New Lambton Heights, 2305 ,","place":["Australia"]},{"name":"John Hunter Hospital Department of Neurology, , New Lambton Heights, 2305 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodney J","family":"Scott","sequence":"additional","affiliation":[{"name":"School of Biomedical Sciences and Pharmacy, University of Newcastle , Callaghan, 2308 ,","place":["Australia"]},{"name":"Immune Health Program, Hunter Medical Research Institute , New Lambton Heights, 2305 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9429-4307","authenticated-orcid":false,"given":"Simon A","family":"Broadley","sequence":"additional","affiliation":[{"name":"School of Medicine and Dentistry, Gold Coast Campus, Griffith University , Southport, 4215 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rod A","family":"Lea","sequence":"additional","affiliation":[{"name":"School of Biomedical Sciences and Pharmacy, University of Newcastle , Callaghan, 2308 ,","place":["Australia"]},{"name":"Immune Health Program, Hunter Medical Research Institute , New Lambton Heights, 2305 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4855-0039","authenticated-orcid":false,"given":"Pernilla","family":"Stridh","sequence":"additional","affiliation":[{"name":"Karolinska Institutet Department of Clinical Neuroscience, , Stockholm, 171 77 ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Olsson","sequence":"additional","affiliation":[{"name":"Karolinska Institutet Department of Clinical Neuroscience, , Stockholm, 171 77 ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Jagodic","sequence":"additional","affiliation":[{"name":"Karolinska Institutet Department of Clinical Neuroscience, , Stockholm, 171 77 ,","place":["Sweden"]},{"name":"Center for Molecular Medicine, Karolinska University Hospital , Stockholm, 171 76 ,","place":["Sweden"]},{"name":"Institute of Environmental Medicine, Karolinska Institutet , Stockholm, 171 77 ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Alfredsson","sequence":"additional","affiliation":[{"name":"Karolinska Institutet Department of Clinical Neuroscience, , Stockholm, 171 77 ,","place":["Sweden"]},{"name":"Center for Molecular Medicine, Karolinska University Hospital , Stockholm, 171 76 ,","place":["Sweden"]},{"name":"Institute of Environmental Medicine, Karolinska Institutet , Stockholm, 171 77 ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2807-0070","authenticated-orcid":false,"given":"Bruce V","family":"Taylor","sequence":"additional","affiliation":[{"name":"MS Research Flagship, Menzies Institute for Medical Research, University of Tasmania , Hobart, 7000 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Ausimmune Investigators Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caron","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Coulthard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Dear","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry","family":"Dwyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor","family":"Kilpatrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robyn","family":"Lucas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"McMichael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Louise","family":"Ponsonby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Valery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"van\u00a0der\u00a0Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6581-3657","authenticated-orcid":false,"given":"Anne-Louise","family":"Ponsonby","sequence":"additional","affiliation":[{"name":"The Florey Institute of Neuroscience and Mental Health, The University of Melbourne , Parkville, 3010 ,","place":["Australia"]},{"name":"Murdoch Children\u2019s Research Institute, The University of Melbourne , Parkville, 3052 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,5,25]]},"reference":[{"key":"2026052703420612300_bib1","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1002\/acn3.50862","article-title":"Environmental and genetic risk factors for MS: an integrated review","volume":"6","author":"Waubant","year":"2019","journal-title":"Ann Clin Transl Neurol"},{"key":"2026052703420612300_bib2","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1126\/science.abj8222","article-title":"Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis","volume":"375","author":"Bjornevik","year":"2022","journal-title":"Science"},{"key":"2026052703420612300_bib3","doi-asserted-by":"publisher","first-page":"103636","DOI":"10.1016\/j.msard.2022.103636","article-title":"Is EBV the cause of multiple sclerosis?","volume":"58","author":"Giovannoni","year":"2022","journal-title":"Mult Scler Relat Disord"},{"key":"2026052703420612300_bib4","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1016\/s0140-6736(81)91527-0","article-title":"Multiple sclerosis and Epstein-Barr virus","volume":"2","author":"Warner","year":"1981","journal-title":"Lancet"},{"key":"2026052703420612300_bib5","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1212\/WNL.0b013e318227062a","article-title":"Current and past Epstein-Barr virus infection in risk of initial CNS demyelination","volume":"77","author":"Lucas","year":"2011","journal-title":"Neurology"},{"key":"2026052703420612300_bib6","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s00705-013-1902-5","article-title":"Classification of HHV-6A and HHV-6B as distinct viruses","volume":"159","author":"Ablashi","year":"2014","journal-title":"Arch Virol"},{"key":"2026052703420612300_bib7","doi-asserted-by":"publisher","first-page":"106031","DOI":"10.1016\/j.micpath.2023.106031","article-title":"Association between human herpesviruses and multiple sclerosis: a systematic review and meta-analysis","volume":"177","author":"Khalesi","year":"2023","journal-title":"Microb Pathog"},{"key":"2026052703420612300_bib8","doi-asserted-by":"publisher","first-page":"211","DOI":"10.4103\/1673-5374.226380","article-title":"Contributions of neurotropic human herpesviruses herpes simplex virus 1 and human herpesvirus 6 to neurodegenerative disease pathology","volume":"13","author":"Hogestyn","year":"2018","journal-title":"Neural Regen Res"},{"key":"2026052703420612300_bib9","doi-asserted-by":"publisher","first-page":"2850","DOI":"10.1002\/jcp.26000","article-title":"Relationship of human herpes virus 6 and multiple sclerosis: a systematic review and meta-analysis","volume":"233","author":"Pormohammad","year":"2018","journal-title":"J Cell Physiol"},{"key":"2026052703420612300_bib10","doi-asserted-by":"publisher","first-page":"362","DOI":"10.3390\/microorganisms12020362","article-title":"From viral infection to autoimmune reaction: exploring the link between human herpesvirus 6 and autoimmune diseases","volume":"12","author":"Sokolovska","year":"2024","journal-title":"Microorganisms"},{"key":"2026052703420612300_bib11","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s00415-025-13248-0","article-title":"Environmental risk factors for multiple sclerosis: a comprehensive systematic review and meta-analysis","volume":"272","author":"Vitturi","year":"2025","journal-title":"J Neurol"},{"key":"2026052703420612300_bib12","doi-asserted-by":"publisher","first-page":"103024","DOI":"10.1016\/j.msard.2021.103024","article-title":"Geographic heterogeneity in the association of varicella-zoster virus seropositivity and multiple sclerosis: a systematic review and meta-analysis","volume":"53","author":"Rice","year":"2021","journal-title":"Mult Scler Relat Disord"},{"key":"2026052703420612300_bib13","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1212\/WNL.0b013e31821e552a","article-title":"Common viruses associated with lower pediatric multiple sclerosis risk","volume":"76","author":"Waubant","year":"2011","journal-title":"Neurology"},{"key":"2026052703420612300_bib14","doi-asserted-by":"publisher","first-page":"3072","DOI":"10.1111\/ene.14961","article-title":"Cytomegalovirus seropositivity is associated with reduced risk of multiple sclerosis\u2014a presymptomatic case-control study","volume":"28","author":"Grut","year":"2021","journal-title":"Eur J Neurol"},{"key":"2026052703420612300_bib15","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1177\/1352458513494489","article-title":"Cytomegalovirus seropositivity is negatively associated with multiple sclerosis","volume":"20","author":"Sundqvist","year":"2014","journal-title":"Mult Scler"},{"key":"2026052703420612300_bib16","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1212\/wnl.0000000000004412","article-title":"Epstein-Barr virus, cytomegalovirus, and multiple sclerosis susceptibility: a multiethnic study","volume":"89","author":"Langer-Gould","year":"2017","journal-title":"Neurology"},{"key":"2026052703420612300_bib17","doi-asserted-by":"publisher","first-page":"102393","DOI":"10.1016\/j.msard.2020.102393","article-title":"Regional differences in the association of cytomegalovirus seropositivity and multiple sclerosis: a systematic review and meta-analysis","volume":"45","author":"Thakolwiboon","year":"2020","journal-title":"Mult Scler Relat Disord"},{"key":"2026052703420612300_bib18","doi-asserted-by":"publisher","first-page":"5705","DOI":"10.1016\/j.cell.2023.11.015","article-title":"Ineffective control of Epstein-Barr-virus-induced autoimmunity increases the risk for multiple sclerosis","volume":"186","author":"Vietzen","year":"2023","journal-title":"Cell"},{"key":"2026052703420612300_bib19","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.1111\/ene.15919","article-title":"Risk of a first clinical diagnosis of central nervous system demyelination in relation to human herpesviruses in the context of Epstein-Barr virus","volume":"30","author":"Lucas","year":"2023","journal-title":"Eur J Neurol"},{"key":"2026052703420612300_bib20","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.3389\/fimmu.2019.02715","article-title":"Increased serological response against human herpesvirus 6A is associated with risk for multiple sclerosis","volume":"10","author":"Engdahl","year":"2019","journal-title":"Front Immunol"},{"key":"2026052703420612300_bib21","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/s41586-022-04432-7","article-title":"Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM","volume":"603","author":"Lanz","year":"2022","journal-title":"Nature"},{"key":"2026052703420612300_bib22","doi-asserted-by":"publisher","first-page":"1304281","DOI":"10.3389\/fimmu.2023.1304281","article-title":"Mimicking the brain: Epstein-Barr virus and foreign agents as drivers of neuroimmune attack in multiple sclerosis","volume":"14","author":"Thomas","year":"2023","journal-title":"Front Immunol"},{"key":"2026052703420612300_bib23","doi-asserted-by":"publisher","first-page":"e126","DOI":"10.1038\/cti.2016.87","article-title":"Defective T-cell control of Epstein-Barr virus infection in multiple sclerosis","volume":"6","author":"Pender","year":"2017","journal-title":"Clin Transl Immunology"},{"key":"2026052703420612300_bib24","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1055\/s-0029-1237423","article-title":"Epigenetics: definition, mechanisms and clinical perspective","volume":"27","author":"Dupont","year":"2009","journal-title":"Semin Reprod Med"},{"key":"2026052703420612300_bib25","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/npp.2012.112","article-title":"DNA methylation and its basic function","volume":"38","author":"Moore","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"2026052703420612300_bib26","doi-asserted-by":"publisher","first-page":"12576","DOI":"10.3390\/ijms241612576","article-title":"DNA methylation signatures of multiple sclerosis occur independently of known genetic risk and are primarily attributed to B Cells and monocytes","volume":"24","author":"Xavier","year":"2023","journal-title":"Int J Mol Sci"},{"key":"2026052703420612300_bib27","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1038\/s41467-018-04732-5","article-title":"DNA methylation as a mediator of HLA-DRB1*15:01 and a protective variant in multiple sclerosis","volume":"9","author":"Kular","year":"2018","journal-title":"Nat Commun"},{"key":"2026052703420612300_bib28","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1002\/ana.78043","article-title":"Epstein\u2013Barr virus, lower vitamin D, low sun exposure, and HLA-DRB1*1501 risk variant share common epigenetic pathways leading to multiple sclerosis onset","volume":"99","author":"Simpson-Yap","year":"2026","journal-title":"Ann Neurol"},{"key":"2026052703420612300_bib29","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1186\/s12864-021-07935-1","article-title":"A validated generally applicable approach using the systematic assessment of disease modules by GWAS reveals a multi-omic module strongly associated with risk factors in multiple sclerosis","volume":"22","author":"Badam","year":"2021","journal-title":"BMC Genomics"},{"key":"2026052703420612300_bib30","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1093\/ije\/dyw277","article-title":"Explanation in causal inference: developments in mediation and interaction","volume":"45","author":"VanderWeele","year":"2016","journal-title":"Int J Epidemiol"},{"key":"2026052703420612300_bib31","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1016\/s1386-6532(06)70004-x","article-title":"HHV-6 and the immune system: mechanisms of immunomodulation and viral escape","volume":"37","author":"Lusso","year":"2006","journal-title":"J Clin Virol"},{"key":"2026052703420612300_bib32","doi-asserted-by":"publisher","first-page":"e0135024","DOI":"10.1128\/jvi.01350-24","article-title":"Role of antiviral CD8+ T cell immunity to SARS-CoV-2 infection and vaccination","volume":"99","author":"Karl","year":"2025","journal-title":"J Virol"},{"key":"2026052703420612300_bib33","doi-asserted-by":"publisher","first-page":"8084","DOI":"10.1093\/nar\/gkz584","article-title":"TERC promotes cellular inflammatory response independent of telomerase","volume":"47","author":"Liu","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"2026052703420612300_bib34","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/gene.2010.46","article-title":"Validation of IRF5 as multiple sclerosis risk gene: putative role in interferon beta therapy and human herpes virus-6 infection","volume":"12","author":"Vandenbroeck","year":"2011","journal-title":"Genes Immun"},{"key":"2026052703420612300_bib35","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1111\/febs.14654","article-title":"Advances and challenges in targeting IRF5, a key regulator of inflammation","volume":"286","author":"Almuttaqi","year":"2019","journal-title":"FEBS J"},{"key":"2026052703420612300_bib36","doi-asserted-by":"publisher","first-page":"205","DOI":"10.5114\/ceji.2017.69363","article-title":"Early growth response 2 and Egr3 are unique regulators in immune system","volume":"42","author":"Taefehshokr","year":"2017","journal-title":"Cent Eur J Immunol"},{"key":"2026052703420612300_bib37","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.cytogfr.2016.04.003","article-title":"The implication of SUMO in intrinsic and innate immunity","volume":"29","author":"Hannoun","year":"2016","journal-title":"Cytokine Growth Factor Rev"},{"key":"2026052703420612300_bib38","doi-asserted-by":"publisher","first-page":"31","DOI":"10.5501\/wjv.v1.i1.31","article-title":"Serological diagnosis of Epstein-Barr virus infection: problems and solutions","author":"De\u00a0Paschale","year":"2012","journal-title":"World J Virol"},{"key":"2026052703420612300_bib39","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1136\/jnnp-2022-330205","article-title":"Increased cytomegalovirus immune responses at disease onset are protective in the long-term prognosis of patients with multiple sclerosis","volume":"94","author":"Comabella","year":"2023","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2026052703420612300_bib40","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1177\/003591576505800503","article-title":"The environment and disease: association or causation?","volume":"58","author":"Hill","year":"1965","journal-title":"Proc R Soc Med"},{"key":"2026052703420612300_bib41","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1177\/1352458507077174","article-title":"Observational analytic studies in multiple sclerosis: controlling bias through study design and conduct. The Australian Multicentre Study of Environment and Immune Function","volume":"13","author":"Lucas","year":"2007","journal-title":"Mult Scler"},{"key":"2026052703420612300_bib42","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1177\/1352458515594040","article-title":"Population attributable fractions and joint effects of key risk factors for multiple sclerosis","volume":"22","author":"van\u00a0der\u00a0Mei","year":"2016","journal-title":"Mult Scler"},{"key":"2026052703420612300_bib43","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1093\/ije\/dyp296","article-title":"Causal thinking and complex system approaches in epidemiology","volume":"39","author":"Galea","year":"2010","journal-title":"Int J Epidemiol"},{"key":"2026052703420612300_bib44","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/1467-9868.00346","article-title":"A direct approach to false discovery rates","volume":"64","author":"Storey","year":"2002","journal-title":"J R Stat Soc Ser B Stat Methodol"},{"key":"2026052703420612300_bib45","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1146\/annurev-publhealth-032315-021402","article-title":"Mediation analysis: a practitioner\u2019s guide","volume":"37","author":"VanderWeele","year":"2016","journal-title":"Annu Rev Public Health"},{"key":"2026052703420612300_bib46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v076.i11","article-title":"medflex: an R package for flexible mediation analysis using natural effect models","volume":"76","author":"Steen","year":"2017","journal-title":"J Stat Softw"},{"key":"2026052703420612300_bib47","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s13059-021-02347-6","article-title":"Genetic impacts on DNA methylation: research findings and future perspectives","volume":"22","author":"Villica\u00f1a","year":"2021","journal-title":"Genome Biol"},{"key":"2026052703420612300_bib48","doi-asserted-by":"publisher","first-page":"3417","DOI":"10.1038\/s41467-019-11052-9","article-title":"Cell-type-specific resolution epigenetics without the need for cell sorting or single-cell biology","volume":"10","author":"Rahmani","year":"2019","journal-title":"Nat Commun"},{"key":"2026052703420612300_bib49","doi-asserted-by":"publisher","first-page":"W782","DOI":"10.1093\/nar\/gkac392","article-title":"WebCSEA: web-based cell-type-specific enrichment analysis of genes","volume":"50","author":"Dai","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"2026052703420612300_bib50","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13059-020-1934-6","article-title":"Lisa: inferring transcriptional regulators through integrative modeling of public chromatin accessibility and ChIP-seq data","volume":"21","author":"Qin","year":"2020","journal-title":"Genome Biol"},{"key":"2026052703420612300_bib51","doi-asserted-by":"publisher","first-page":"D1353","DOI":"10.1093\/nar\/gkac1046","article-title":"The next-generation Open Targets Platform: reimagined, redesigned, rebuilt","volume":"51","author":"Ochoa","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"2026052703420612300_bib52","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s40263-024-01153-5","article-title":"Repurposing licensed drugs with activity against Epstein-Barr virus for treatment of multiple sclerosis: a systematic approach","volume":"39","author":"Li","year":"2025","journal-title":"CNS Drugs"}],"container-title":["Environmental Epigenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eep\/article-pdf\/12\/1\/dvag016\/68379929\/dvag016.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eep\/article-pdf\/12\/1\/dvag016\/68379929\/dvag016.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T07:42:13Z","timestamp":1779867733000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eep\/article\/doi\/10.1093\/eep\/dvag016\/8692383"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2,16]]}},"URL":"https:\/\/doi.org\/10.1093\/eep\/dvag016","relation":{},"ISSN":["2058-5888"],"issn-type":[{"value":"2058-5888","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026]]},"published":{"date-parts":[[2026]]},"article-number":"dvag016"}}